Another group led by Christian Rolfo reported the identification of EML4-ALK inversion in exosomes (ExoALK) from 1 mL plasma samples using next-generation sequencing: 19 NSCLC patients, out of which 16 were confirmed ALK+ in tissue, were evaluated. Here, EML4 is linked to non-small cell lung carcinoma.